This review summarizes mechanistic evidence and clinical studies on hypertension in metabolic syndrome and diabetes to guide clinical management.
May inform BP targets in metabolic syndrome and diabetes; leaves open optimal regimens pending dedicated RCTs.
The increasing prevalence of obesity, hypertension, and abnormal glucose metabolism is a major challenge to health care in industrialized societies. This brief review summarizes the mechanistic evidence and clinical studies related to the problem of hypertension in the metabolic syndrome and diabetes to allow clinicians to provide more effective and enlightened management of these common, interrelated problems.
No takes yet. Share an insight, caveat, or question.
Joseph L. Izzo (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: